Aug 15, 2022 by James HalleyWhy Liquidia Shares Rose 18.4% on MondayOptimism by the company regarding a patent ruling is encouraging investors.
Aug 12, 2022 by James HalleyWhy Invitae Corporation Stock Jumped 23% This WeekThe stock had a big climb after its second-quarter report.
Aug 10, 2022 by James Halley2 Cannabis Stocks You Can Buy and Hold for the Next DecadeThese two companies are already profitable, and at their current share prices, they're solid long-term buys.
Aug 9, 2022 by James HalleyWhy Shares of Co-Diagnostics Stock Fell 10% on TuesdayThe stock dropped two days before reporting second-quarter earnings.
Aug 8, 2022 by James HalleyWhy Shares of Abiomed Rose 18.4% in JulyThe company's stock rose steadily throughout the month.
Aug 7, 2022 by James HalleyWhy Shares of Align Technology Rose 18.7% in JulyInvestors shrugged off a so-so second-quarter report.
Aug 7, 2022 by James HalleyBuying These 2 Stocks Is a Good Way to Hedge Against a Market CrashConsumers turn to these two retailers in recessions to save money.
Aug 6, 2022 by James HalleyWhy Twist Bioscience's Shares Rose 25.1% in JulyTwo bits of positive news spurred the stock's rise.
Aug 1, 2022 by James HalleyWhy Shares of MannKind Corporation Climbed 10.4% on MondayThe company is coming off an FDA approval for its second marketed drug.
Jul 30, 2022 by James Halley2 Biotech Stocks That Could Help Make You a FortuneThese companies have seen triple-digit revenue growth in recent years.
Jul 29, 2022 by James HalleyWhy Virax Biolabs Stock Plummeted 74% On FridayThe stock had a wild trading day with an initial upswing, followed by a strong downtrend.
Jul 28, 2022 by James HalleyWhy Shares of Bausch Health Companies Dropped 54.4% This WeekA patent-court loss sent investors scurrying to the exits.
Jul 27, 2022 by James HalleyWhy Legend Biotech's Shares Jumped 11.8% on WednesdayInvestors, on second glance, might think the company's stock offering is a good idea.
Jul 26, 2022 by James HalleyWhy Shares of Agenus Inc. Rose 10.1% on TuesdayThe company has a promising colon cancer therapy.
Jul 22, 2022 by James HalleyWhy Shares of Verve Therapeutics Shot Up 44.9% This WeekThe gene-editing company is getting an infusion of cash.
Jul 22, 2022 by James Halley2 Biotech Stocks to Help Recession-Proof Your PortfolioThese companies' shares have outpaced the market and other biotech stocks this year.
Jul 21, 2022 by James HalleyWhy GlaxoSmithKline Stock Jumped 25% on ThursdayInvestors may be warming to the company's spin-off of its consumer healthcare division.
Jul 18, 2022 by James HalleyWhy Shares of Clene Jumped 11.8% on MondayThe company's lead therapy has shown progress against ALS in preliminary trials.
Jul 15, 2022 by James HalleyWhy Shares of Canopy Growth Sank 18.7% This WeekThe drop is a continuation of the stock's downward trend this year.
Jul 13, 2022 by James Halley3 Explosive Pot Stocks to Buy in 2022 and BeyondThese three companies have a solid track record of growth that belies their falling share prices.
